{
    "clinical_study": {
        "@rank": "141289", 
        "arm_group": [
            {
                "arm_group_label": "the treatment group A", 
                "description": "The people in treatment group were regrafted with thin split-thickness skin graft"
            }, 
            {
                "arm_group_label": "the control group B", 
                "description": "The group B covered with the occlusive hydrocellular dressing (Allevyn Adhesive, Smith & Nephew)"
            }, 
            {
                "arm_group_label": "the control group C", 
                "description": "Group C were covered with paraffin gauze"
            }
        ], 
        "brief_summary": {
            "textblock": "Split-thickness skin grafting remains fundamental treatment of patients with deep burns and\n      other traumatic injuries. However, the split-thickness skin graft (STSG) donor site dressing\n      has been controversial until now. Our study here aimed to assess patient comfort and\n      wound-healing efficacy with the application of thin split-thickness grafting on STSG donor\n      sites."
        }, 
        "brief_title": "Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Skin Graft Disorder", 
            "Disorder of Skin Donor Site", 
            "Wound Healing Disturbance of"
        ], 
        "condition_browse": {
            "mesh_term": "Skin Diseases"
        }, 
        "detailed_description": {
            "textblock": "Background\uff1aSplit-thickness skin grafting remains fundamental treatment of patients with deep\n      burns and other traumatic injuries. However, the split-thickness skin graft (STSG) donor\n      site dressing has been controversial until now. Our study here aimed to assess patient\n      comfort and wound-healing efficacy with the application of thin split-thickness grafting on\n      STSG donor sites.\n\n      Methods: 192 consecutive patients undergoing split-thickness skin grafting were included in\n      the study and the participants were randomly divided into three groups: Group A was\n      regrafted with thin STSG, while, Group B and Group C were covered with the occlusive\n      hydrocellular dressing and paraffin gauze, respectively. The three groups were compared\n      regarding to the time of epithelialization, pain sensed by the patients and the scar\n      formation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who continuously received an STSG from January 2002 to December 2010 in\n             Department of Burn and Plastic Surgery, Tangdu Hospital, Fourth Military Medical\n             University\n\n        Exclusion Criteria:\n\n          -  The patients who were significant psychiatric, hypersensitive to silver, and not be\n             followed up were excluded"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "56 Years", 
            "minimum_age": "5 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study cohort included 192 participants, who were randomly selected from patients who\n        continuously received an STSG from January 2002 to December 2010 in Department of Burn and\n        Plastic Surgery, Tangdu Hospital, Fourth Military Medical University."
            }
        }, 
        "enrollment": {
            "#text": "192", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974583", 
            "org_study_id": "TDLL-2030130"
        }, 
        "intervention": [
            {
                "arm_group_label": "the treatment group A", 
                "description": "Group A (the treatment group) were regrafted with thin split-thickness skin graft", 
                "intervention_name": "regrafted with thin split-thickness skin graft", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "the control group B", 
                "description": "group B covered with the occlusive hydrocellular dressing (Allevyn Adhesive, Smith & Nephew)", 
                "intervention_name": "covered with the occlusive hydrocellular dressing", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "the control group C", 
                "description": "Group C covered with paraffin gauze", 
                "intervention_name": "covered with paraffin gauze", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "the split-thickness skin graft \uff08STSG\uff09 donor site", 
            "regraft", 
            "wound healing"
        ], 
        "lastchanged_date": "October 27, 2013", 
        "number_of_groups": "3", 
        "official_title": "Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting", 
        "other_outcome": {
            "description": "Scar formation of skin donor sites was evaluated by Vancouver scar scale in terms of colour, vascular distribution, thickness and scratchability 6-12 months after surgery", 
            "measure": "Scar formation of skin donor site", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "overall_official": {
            "affiliation": "specify Unaffiliated", 
            "last_name": "Yongqian Bian, doctor", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The time of epithelialization was observed every 3 days", 
            "measure": "The time of epithelialization", 
            "safety_issue": "Yes", 
            "time_frame": "up to 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974583"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tang-Du Hospital", 
            "investigator_full_name": "Yongqian Bian", 
            "investigator_title": "Mr Yongqian Bian", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Pain sensed by the patients was assessed by Wong-Baker FACES Pain Rating Scale on day 2 and 5 after surgery", 
            "measure": "Pain sensed by the patients", 
            "safety_issue": "Yes", 
            "time_frame": "up to 6 months"
        }, 
        "source": "Tang-Du Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tang-Du Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2002", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "October 2013"
    }
}